WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for Mirati Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-08 10:14 am Sale |
2023-12-29 | 13G | Mirati Therapeutics, Inc. MRTX |
WELLINGTON MANAGEMENT CO LLP | 0 0.000% |
-3,016,335 (Position Closed) |
Filing |
| 2023-02-06 2:53 pm Sale |
2022-12-30 | 13G | Mirati Therapeutics, Inc. MRTX |
WELLINGTON MANAGEMENT CO LLP | 3,016,335 5.240% |
-129,297 (-4.11%) |
Filing |
| 2022-02-04 09:21 am Purchase |
2021-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
WELLINGTON MANAGEMENT CO LLP | 3,145,632 5.700% |
3,145,632 (New Position) |
Filing |